Amazon-owned Bee has launched its first new AI devices since its acquisition, including an updated wearable and a credit-card-sized recorder that attaches to smartphones. The devices can summarize conversations, create to-do lists, and integrate with Alexa and Amazon shopping, with prices starting at $74.99.
There’s a new digital pet in town – a cute little marshmallow of a robot that can change its cartoony expressions to match your mood. But if you or your kids talk to “Eiliko” over Wi-Fi, it’ll phone home to China. Its AI companion can store literally everything you tell it on Chinese servers, where […]
Big Walk’s co-op multiplayer walking adventure has proved popular since launching in August, but Xbox players have been excluded from the fun – and now the game’s creators have explained why. Developer House House said in a blog post that it decided not to release Big Walk on Xbox consoles in accordance with the Palestinian-led […]
The digital rights unit found evidence that dozens of devices at media organization Al Jazeera were hacked after being shown malicious online ads.
The founders detailed how their startup is developing AI that can design chips, learn from each iteration, and improve subsequent designs, all with the goal of automating and accelerating the chip design process.
At TechCrunch Disrupt, Flock CEO Garrett Langley defended his company’s surveillance technology despite growing privacy concerns, arguing that its crime-fighting benefits outweigh the risks of abuse.
It’s time to unveil the five companies that will be competing in the Startup Battlefield finals.
Every day, conversations unfold across social media and websites around the world. A seemingly insignificant post—whether it involves AI-generated misinformation, hate speech, or a damaging rumor—can quickly snowball into a much larger public controversy. Gudea, a company that tracks how stories and rumors spread online that describes itself as the “storm tracker for the internet,” […]
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
